
Indonesian solar panel manufacturers brush off potential US tariffs
Beny Sulaiman, business development and commercial director at PT Jembo Energindo, told The Jakarta Post on Wednesday (July 30) that 'the concerns in Indonesia are relatively small' since the domestic market could absorb locally made solar panels, as long as the government supported this.
'Indonesia is a big country with abundant market potential for renewables. On top of that, the government has been very supportive in significantly increasing [the share of] renewables in the [national] energy mix,' said Beny, who is also an executive at the Indonesian Solar Module Manufacturers Association.
The trade petitions, which seek to impose antidumping and countervailing duties, were filed earlier this month by the American Alliance for Solar Manufacturing Trade Committee, according to a Bloomberg article.
The group includes major US-based manufacturers like First Solar, Mission Solar Energy and Qcells. The plaintiffs allege that Chinese solar panel producers are flooding the US market with unfairly cheap goods made in factories in Indonesia, Laos and India.
The petitions' filing has kicked off a process in which the Commerce Department has 20 days to decide whether to investigate the allegation that imports are unfairly priced or subsidised by a foreign government.
Separately, the US International Trade Commission is to determine whether the imported solar panels harm domestic competition.
If the commerce and trade authorities conclude that the imports are unfair and injurious. Washington might impose new duties on foreign-made solar panels.
This process played out previously in April, when the US government imposed import duties of 3,521 per cent on certain solar power equipment from Cambodia, a year after the same industry alliance petitioned for protection of its members' operations.
Three other South-East Asian countries, Malaysia, Thailand and Vietnam, were also imposed US duties of varying rates, depending on the manufacturer and the products' origin. China-based Trina Solar was subject to a 375 per cent tariff for its products manufactured in Thailand, while China's Jinko Solar was slapped with a 41 per cent tariff on its Malaysian-made products.
The US imported solar equipment from the four countries totaling almost US$12 billion, the BBC reported in April, citing US Census Bureau figures. The antidumping and countervailing duties have caused a massive shift in the US solar industry supply chain, prompting an immediate decline in shipments from Cambodia, Malaysia, Thailand and Vietnam in May, with Indonesia and Laos picking up the slack.
Indonesia and Laos saw its solar panel exports to the US balloon to 44 per cent in May from a figure of just 1.9 per cent n May 2024, Bloomberg reported. Meanwhile, India's solar panel exports to the US have been on the rise since 2022.
Many Chinese firms have moved their operations to South-East Asia in recent years in a bid to avoid US tariffs since President Donald Trump's first term in 2017-2021. Anindya Bakrie, chairman of the Indonesian Chamber of Commerce and Industry (Kadin), and Shinta Kamdani, chairwoman of the Indonesian Employers Association (Apindo), both said they had not yet caught up with the matter when the Post contacted them for comments on Tuesday.
Fabby Tumiwa, executive director of the Institute for Essential Services Reform, told the Post on Wednesday that US solar manufacturers had filed the trade petitions because they were unable to compete with imported solar products. 'The production cost of solar modules in the US is higher than in other countries. Compared to Southeast Asia, China or India, they're far more expensive,' he said.
According to Fabby, Chinese solar technologies from were 60 per cent cheaper than those produced in the US. Likewise, Indian and South-East Asian solar panels cost only 20-30 per cent more than those made in China.
Fabby suggested that US solar manufacturers were 'under heavy pressure', given that they had only recently commenced production and had therefore 'not reached the economies of scale'.
Meanwhile they faced short deadlines, according to Fabby, who said manufacturers had to break even in three years as the industry was advancing rapidly, with new and more efficient solar technologies pushing out previous generations in a cycle of three to five years.
'If they cannot break even in three years, they'll certainly be left behind, because the Chinese move very fast,' he said. 'That's why it's in [US manufacturers'] best interest to shave imports, so they can utilise domestic capacity.'
The condition of US solar manufacturers has been exacerbated by the 50 per cent import tariffs the Trump administration has imposed on aluminum and steel, two important precursors for solar technology, driving production costs even higher.
While the pressure on the US solar industry was understandable, 'it's unfair to blame other countries [where] production costs are lower', said Fabby, adding that Indonesia's solar panel manufacturers had achieved competitiveness fair and square, without any government subsidies. - The Jakarta Post/ANN
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Star
2 minutes ago
- The Star
Backbenchers Club praises Anwar for US tariff reductions benefiting SMEs
PETALING JAYA: The Backbenchers Club (BBC) commended Prime Minister Anwar Ibrahim on the recent tariff reduction by the United States, as it also enables small and medium-sized enterprises (SMEs) to achieve long-term competitiveness in high-growth sectors. The tariff was reduced from 25% to 19%. 'These efforts are essential not only to absorb the impact of global trade fluctuations but to position Malaysian companies, especially SMEs, for long-term competitiveness in high-growth sectors,' said BBC in a statement on Friday (Aug 1). Although this is a positive step, the BBC highlighted the need to persist with economic reform, expand into new markets, and develop a resilient economy. 'I commend the Prime Minister for defending that space while keeping the door open to meaningful trade engagement with one of our largest partners,' said the statement According to a report in The Star, the new tariff structure would take effect in seven days and apply to goods entering the US for consumption, with limited exceptions for shipments already in transit.

The Star
2 minutes ago
- The Star
Bernama inks collaboration with HIMC to promote tourism, drive economic growth
KUALA LUMPUR: The Malaysian National News Agency (Bernama) formalised a strategic collaboration with Hainan International Media Center (HIMC) to enhance the promotion of Malaysia's tourism industry and stimulate economic growth. Bernama Chairman Datuk Seri Wong Chun Wai said the news agency is prepared to play an active role in showcasing distinctive local tourism offerings to attract more international visitors, especially from China. 'This marks the first collaboration between Bernama and HIMC to showcase Malaysia's tourism industry and investment landscape through media platforms. "They are eager to discover and help highlight local products and notable tourist destinations in Malaysia, such as the scenic beaches of Penang and Terengganu, to audiences in China," he told Bernama after the signing ceremony here on Friday (Aug 1). He said Malaysia would also serve as a strategic partner in promoting tourism in Hainan province, which offers more affordable travel options compared to other destinations. The partnership was formalised under the New International Land-Sea Trade Corridor Cultural Cooperation Alliance, which brings together HIMC and several Malaysian organisations, including Bernama, Kwong Wah Yit Poh, Nanyang Siang Pau, MILA University, the Federation of Hainan Association Malaysia, and the Malaysia Asean-China Economic and Trade Development Promotion Association. The alliance aims to foster closer collaboration between media and cultural organisations in Malaysia and China, focusing on supporting content co-production, talent development and policy coordination. Additionally, the alliance places a strong emphasis on youth collaboration, with institutions such as MILA University in Malaysia and the Lingshui Haifeng International Film and Television Base in Hainan, which cooperate on exchange programmes, creative workshops, and training initiatives to nurture regional talent. Meanwhile, HIMC's Senior Advisor on Hainan-Asean International Communication, Dr Pua Eng Teck, said Malaysia was chosen as a strategic hub due to its strong historical and cultural ties with the Malaysian Chinese community, particularly in the fields of business, culture and information exchange. 'Kuala Lumpur is the central city of Malaysia, offering strategic geographical advantages and greater opportunities to foster people-to-people and business-to-business connections,' he said. Beyond business collaboration, Dr Pua also highlighted the benefits for students, especially those from China pursuing higher education in Malaysia. 'HIMC plays a key role not just in promoting cultural ties, but also in supporting educational exchange. It provides a strong platform for Chinese students studying in Malaysia to engage more deeply with local communities and institutions,' he added. – BERNAMA


The Sun
2 minutes ago
- The Sun
Life Sciences on the Chinese Mainland – Vital signs: Diagnosing trends in the life sciences real estate market on the Chinese mainland
HONG KONG SAR - Media OutReach Newswire - 1 August 2025 - Cushman & Wakefield, a leading global real estate services firm, today released its Life Sciences on the Chinese Mainland – Vital signs: Diagnosing trends in the life sciences real estate market on the Chinese mainland report. It is based on in-depth interview surveys we conducted on professionals active in the life sciences sector on the Chinese mainland. The life sciences industry on the Chinese mainland is undergoing a transformative phase, driven by progressive policies, groundbreaking innovations, the emergence of influential life sciences companies, and strategic regional development. This report delves into the latest trends shaping the sector. Policy Landscape – National and Local Catalysts Reforms enacted in 2024-2025 have significantly accelerated sector development. Nationally, China relaxed restrictions on foreign investment in gene and cell therapy and allowed the establishment of wholly foreign-owned hospitals in key cities. Regulatory incentives – such as data protection and marketing exclusivity – have improved market access for innovative drugs. Locally, cities like Beijing, Shanghai, Shenzhen, Guangzhou, and Suzhou are rolling out targeted subsidies, fast-track approvals, and ecosystem-building programmes that directly benefit biotech development. Recent national policy initiatives on the Chinese mainland Industry Innovation and Company Growth Chinese life sciences companies are moving beyond generic drug manufacturing toward innovative therapies. Firms like Akeso, BeiGene, Gracell, and Legend Biotech are now global players, leading in CAR-T, bispecific antibodies, and AI-assisted R&D. These companies are not only commercialising cutting-edge treatments but also attracting international investment and licensing agreements, reinforcing the Chinese mainland's global relevance in life sciences. Real Estate Development and Regional Hubs Innovation hubs such as Suzhou BioBAY, Zhangjiang Hi-Tech Park (Shanghai), and the Bioisland Innovation Centre (Guangdong) are central to regional clustering. These hubs offer end-to-end support, including shared labs, venture capital access, GMP-compliant facilities, and proximity to academic and clinical networks. The rise of second-tier innovation cities like Chengdu and Ningbo further expands growth corridors. The 'R&D + Manufacturing + Service' ecosystem Source: Cushman & Wakefield Research Landlord Perspectives – Evolving Real Estate Models Real estate developers and landlords are adapting to sector-specific requirements through asset-light models, flexible leasing, and high-specification lab and production space. Tier-1 cities face saturation, but central and western regions exhibit healthy demand. Developers are incorporating advanced sustainability and compliance features to meet growing regulatory and ESG expectations, particularly in GMP and cleanroom environments. Digitalisation, environmental policies, and differentiated tenant strategies are shaping performance. Operators now focus on integrated ecosystems with platforms that link tenants to R&D services, policy benefits, and technology partners. Occupier Perspectives – Growth, Innovation, and Challenges Life sciences occupiers are navigating regulatory reform, rising compliance demands, and intensified market competition. Many are localising production and R&D, leveraging regional subsidies, and investing in AI-powered innovation platforms. Occupiers seek flexibility, proximity to talent and infrastructure, and co-located R&D and manufacturing to support accelerated innovation and operational agility. In real estate, demand is strongest for GMP-certified labs, modular production facilities, and shared innovation platforms. Occupiers emphasise location advantages, sustainability certifications (e.g., LEED, WELL), and integration into clusters that enable faster time-to-market. Tony Su, Managing Director, National Head of Industrial & Logistics Property Services, China, said, 'Life sciences business parks on the Chinese mainland demonstrated clear regional differentiation, highlighting opportunities for strategic positioning. While Tier-1 cities saw more moderate performance due to broader macroeconomic factors and abundant supply, core cities in central and western regions recorded healthy occupancy rates, underpinned by strong industrial clustering and increasingly sophisticated ecosystems – contributing to steady growth in asset value.' Johnathan Wei, President, Project & Occupier Services, China, said, 'Several interviewed life sciences companies on the Chinese mainland achieved revenue growth supported by innovative products and favourable policy tailwinds. While overall growth remained modest for many, a select group reported strong performance, highlighting opportunities for differentiation'. Andrew Chan, Managing Director, Head of Valuation & Advisory Services, Greater China, said,' Looking ahead to 2025 and beyond, growth opportunities lie in AI-driven drug discovery, personalised medicine, advanced therapeutics (CGT, RNA), and green-certified facilities. Government policies continue to support innovation through fast-track approvals, rare disease funding, and subsidies aligned with dual-carbon and ESG goals'. Shaun Brodie, Head of Research Content, Greater China, 'Life sciences real estate is shifting from generic parks to specialised, digitally enabled campuses with high compliance and flexibility. Investment strategies increasingly emphasise long-term partnerships, collaborative operating models, and digital infrastructure. Both landlords and occupiers express cautious optimism, with strategic differentiation and regional targeting seen as keys to unlocking future value'. Please click here to download the full report.